JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
LCNB Corp
LCNB
$284M
| $1.09M | ﹤0.01% |
56,515
+6,991
| +14% | +$128K |
|
3627
Novavax
NVAX
$1.34B
| $1.09M | ﹤0.01% |
274,321
-7,727
| -3% | -$33.5K |
|
3628
PUT
Liberty Global Class C
LBTYK
$3.48B
| $1.09M | ﹤0.01% |
+50,000
| New | +$1.12M |
|
|
ZNGA
3629
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.09M | ﹤0.01% |
178,002
-80,173
| -31% | -$496K |
|
3630
Liberty Energy
LBRT
$3.44B
| $1.09M | ﹤0.01% |
97,646
+59,777
| +158% | +$567K |
|
3631
Inspire Medical Systems
INSP
$1.68B
| $1.08M | ﹤0.01% |
14,621
-14,281
| -49% | -$918K |
|
3632
iShares Mortgage Real Estate ETF
REM
$547M
| $1.08M | ﹤0.01% |
24,360
+379
| +2% | +$16.4K |
|
3633
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.8B
| $1.08M | ﹤0.01% |
27,785
+448
| +2% | +$17.9K |
|
3634
Artesian Resources
ARTNA
$369M
| $1.08M | ﹤0.01% |
28,956
+7,659
| +36% | +$283K |
|
3635
Artivion
AORT
$1.39B
| $1.08M | ﹤0.01% |
39,737
+27,784
| +232% | +$683K |
|
3636
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
| $1.08M | ﹤0.01% |
34,000
-10,301
| -23% | -$329K |
|
|
DCH
3637
CALL
Dauch Corp
DCH
$1.61B
| $1.08M | ﹤0.01% |
+100,000
| New | +$952K |
|
3638
Hingham Institution for Saving
HIFS
$687M
| $1.08M | ﹤0.01% |
5,118
+185
| +4% | +$35.7K |
|
3639
CALL
Agilent Technologies
A
$42.2B
| $1.07M | ﹤0.01% |
12,600
-17,400
| -58% | -$1.37M |
|
|
EVBG
3640
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.07M | ﹤0.01% |
13,766
-34,059
| -71% | -$2.63M |
|
|
MRNS
3641
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.07M | ﹤0.01% |
124,380
+120,267
| +2,924% | +$675K |
|
3642
AZZ Inc
AZZ
$4.52B
| $1.07M | ﹤0.01% |
23,316
-336
| -1% | -$13.7K |
|
3643
Hilton Grand Vacations
HGV
$3.49B
| $1.07M | ﹤0.01% |
31,119
-434,038
| -93% | -$14.9M |
|
3644
Takeda Pharmaceutical
TAK
$55.6B
| $1.07M | ﹤0.01% |
54,237
+29,026
| +115% | +$555K |
|
|
YMAB
3645
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.07M | ﹤0.01% |
34,233
-963
| -3% | -$28.5K |
|
3646
CryoPort
CYRX
$766M
| $1.07M | ﹤0.01% |
64,857
+44,292
| +215% | +$659K |
|
3647
Horizon Bancorp
HBNC
$1.05B
| $1.07M | ﹤0.01% |
56,240
+43,392
| +338% | +$796K |
|
3648
HCI Group
HCI
$2.32B
| $1.07M | ﹤0.01% |
23,388
+8,866
| +61% | +$391K |
|
|
BGX
3649
Blackstone Long-Short Credit Income Fund
BGX
$139M
| $1.07M | ﹤0.01% |
68,252
+41
| +0.1% | +$632 |
|
3650
Vericel Corp
VCEL
$2.28B
| $1.07M | ﹤0.01% |
61,341
+46,925
| +326% | +$799K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.